• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Botanical Extraction

Psychedelic Mushrooms: Tryptamines, Psilocin and Psilocybin

Asia Mayfield by Asia Mayfield
May 9, 2023
in Botanical Extraction, Psychedelics
Psychedelic Mushrooms: Tryptamines, Psilocin and Psilocybin

Tryptamines are a class of organic compounds found in plants, animals, and fungi. Many psychedelic drugs fall into the tryptamine category, including the well-known hallucinogenic substances psilocin and psilocybin, which come from certain kinds of mushrooms.

 These compounds are capable of inducing profound alterations in thought, perception, and consciousness and are responsible for why some mushroom species are called “magic”. It’s a growing market, with “magic” stores and whole chains like Funguyz magic mushrooms popping up all over the United States and Canada.

READ ALSO

CBD‑Specific Gear Hits US $65 M Market Milestone

Turnkey Extraction and Purification Units for Cannabis Processing

While mushroom tryptamines have been consumed as recreational drugs or spiritual aids for centuries, they’re increasingly being studied for their potential therapeutic benefits. 

What Are Tryptamines?

Tryptamines are monoamine alkaloid compounds with an indole ring structure. They are found in a wide range of organisms and account for some of the most important biogenic amines.

Within mammals, tryptamines play many roles, including acting as neurotransmitters that regulate mood and behavior. The most well-known endogenous tryptamine is serotonin, which influences energy levels and mood. Other endogenous tryptamines include melatonin (regulates sleep cycles) and bufotenin (involved in pain regulation).

In plants, tryptamines act as a kairomone–a chemical messenger that influences the behavior of other organisms. For instance, naphthalene is a tryptamine found in some plant species which affects the behavior of insects.

Mushroom tryptamines, such as psilocybin and psilocin, are known for their psychedelic effects. There are over 200 species of psychedelic mushrooms, each with varying potency. For example, Shiva Lingam mushrooms average 1.98% tryptamine content, while the Tidal Wave variety averages 1.17%

Psilocin and Psilocybin

Psilocin is a compound that acts on serotonin receptors in the brain, producing an altered state of consciousness. Psilocybin is a prodrug which means that when it is ingested, it converts into the active ingredient psilocin in the body.

The effects of psilocin vary, depending on the ingested amount, the environment in which they are ingested, and the individual’s mental state at the time. However, the effects are often reported as positive.

Researchers are currently studying mushrooms tryptamines as treatment for depression, anxiety and other mental disorders. Most studies use synthetic psilocybin because it can be difficult to create stable synthetic psilocin.

Psilocin and the Brain

Psilocin has a powerful effect on the brain.

Its molecules share a similar structure to serotonin, allowing it to activate many of the same receptors, particularly the 5HT2A receptor site. These receptors are concentrated in the cortex and may have a large influence on brain activity.

Research also suggests that psilocin affects the Default Mode Network (DMN), a part of your brain often referred to as the information highway. Psilocin can disrupt the DMN, so the brain is forced to make new connections.

“When someone’s on psilocybin, we see an overall increase in connectivity between areas of the brain that don’t normally communicate well,” explains Matthew Johnson, a professor in psychedelics and consciousness at Johns Hopkins Medicine. “You also see the opposite of that – local networks in the brain that normally interact with each other quite a bit suddenly communicate less.”

Psilocybin and Depression

Studies have shown that psilocybin can reduce symptoms of depression and anxiety in individuals with treatment-resistant depression, and the effects may last weeks or even months after a single dose. 

David Nutt, director of the Neuropsychopharmacology Unit at Imperial College London, believes that psilocybin helps depressed patients because it opens their minds to new pathways and thoughts. “Depressed people are continually self-critical, and they keep ruminating, going over and over the same negative, anxious or fearful thoughts… Psychedelics disrupt that.”

Psilocybin may also provide psychological relief to patients with life-threatening illnesses. A 2016 study found that a single dose of psilocybin reduced depression and death anxiety in terminal cancer patients. 

Conclusion

Tryptamines are a diverse class of compounds found in lifeforms across the earth. Psilocybin and psilocin, two naturally occurring tryptamines found in psychedelic mushrooms, can produce powerful psychological effects.

Recent research suggests that these molecules may be useful for treating depression and anxiety, as well as helping people with serious illnesses better cope with their condition.

These studies indicate that psilocybin may be a promising treatment for mental disorders, although more research is needed to explore its potential applications.

References:

  1. Greene, Shaun. “Tryptamines.” Novel Psychoactive Substances, 2013, pp. 363-381, https://doi.org/10.1016/B978-0-12-415816-0.00015-8. Accessed 20 Apr. 2023.
  2. Tittarelli, Roberta et al. “Recreational use, analysis and toxicity of tryptamines.” Current neuropharmacology vol. 13,1 (2015): 26-46. doi:10.2174/1570159X13666141210222409
  3. Gukasyan N, Davis AK, Barrett FS, et al. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology. 2022;36(2):151-158. doi:10.1177/02698811211073759
  4. Griffiths, Roland R et al. “Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.” Journal of psychopharmacology (Oxford, England) vol. 30,12 (2016): 1181-1197. doi:10.1177/0269881116675513

Related Posts

Modern CBD extraction equipment in a commercial cannabis processing facility
Botanical Extraction

CBD‑Specific Gear Hits US $65 M Market Milestone

September 22, 2025
Turnkey cannabis extraction lab equipment integrating extraction, purification, and distillation in a single automated system
Botanical Extraction

Turnkey Extraction and Purification Units for Cannabis Processing

July 1, 2025
Wide angle view at two workers wearing protective suits while inspecting production at modern chemical plant, copy space
Botanical Extraction

Collaborative Approaches in Botanical Extraction: Bridging Science and Industry

June 7, 2025
Taxonomic Framework of Cannabis
Cannabinoids

The Taxonomic Framework of Cannabis: Nomenclature of Nugs

May 29, 2025
The Art of Extraction: Unlocking Nature’s Fragile Secrets
Botanical Extraction

The Art of Extraction: Unlocking Nature’s Fragile Secrets

May 15, 2025
Areca Catechu
Botanical Extraction

Inside the Betel Nut High: Exploring the Mind-Bending Effects of Areca Catechu

May 1, 2025
Next Post
Antioxidants in plants and extraction methods

Antioxidants in plants and extraction methods

LATEST ARTICLES

Modern CBD extraction equipment in a commercial cannabis processing facility

CBD‑Specific Gear Hits US $65 M Market Milestone

September 22, 2025
Buffalo Hybrid Extraction System

Multi‑Tech Platforms: Hybrid Extraction On Tap

July 20, 2025
AI-powered cannabis cultivation system optimizing terpene and cannabinoid production with real-time data analytics

How AI-Designed Formulas Just Cracked the $2.3B Terpene Code

July 14, 2025
Cannabis oil and concentrates representing the booming extracts market projected at $16.6 billion in 2025

Cannabis Extracts Market Projected at US $16.6 B in 2025

July 7, 2025

Subscribe Now

Subscribe to our newsletter now to receive quick updates from us



    Background
    About

    Extraction Magazine is the trusted provider of botanical extraction news, ever-changing politics, cool gadgets and technologies, and methods for producing safe, ethical, and compliant formulations.

    Advertisers
    Navigation
    • Botanical Extraction
    • Industry News
    • Extraction Technology
    • Medical Research
    • Glossary
    • Business Directory
    Recent Posts
    • CBD‑Specific Gear Hits US $65 M Market Milestone
    • Multi‑Tech Platforms: Hybrid Extraction On Tap
    • How AI-Designed Formulas Just Cracked the $2.3B Terpene Code
    • Cannabis Extracts Market Projected at US $16.6 B in 2025
    Subscribe to our Newsletter
    loader

    Sitemap

    © 2025 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

    No Result
    View All Result
    • Industry News
    • Botanical Extraction
    • Medical Research
    • Medical Research
    • Glossary
    • Our Team
    • Write For Us

    © 2023 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.